ATI Hematologic System
A health care professional is caring for a patient who is about to begin iron dextran (INFeD) therapy. When administering the drug IM, the health care professional should take which of the following actions? (Select all that apply) a) Administer a test dose b) Monitor blood pressure c) Have epinephrine available d) Premedicate with atropine e) Use the Z-track technique
a) Administer a test dose b) Monitor blood pressure c) Have epinephrine available d) Use the Z-track technique
A health care professional is preparing to administer the prescribed dose of filgrastim (Neupogen) to a patient. The patient's laboratory results indicate that the patient has a WBC count of 12,000 mm3. Which of the following actions should the health care professional take? a) Clarify the prescription within the provider. b) Administer the drug with an analgesic c) Limit venipunctures d) Assess breath sounds
a) Clarify the prescription within the provider.
A health care professional is caring for a patient who is about to begin taking oprelvekin (Neumega) to treat thrombocytopenia. The healthc are professional should tell the patient to report which of the following idications of an adverse reaction? (select all that apply). a) Conjuctivitis b) Tinnitus c) Swollen ankles d) Jaundice e) Palpitations
a) Conjuctivitis c) Swollen ankles e) Palpitations
A health care professional is caring for a patient who is about to begin taking clopidogrel (Plavix) to prevent stent stenosis. The health care professional should monitor the patient for which of the following adverse reactions? a) Thrombocytopenia b) Hyponatremia c) Lymphocytopenia d) Uricemia
a) Thrombocytopenia
A health care professional should assess a patient who has megaloblastic anemia for indications of which of the following vitamin deficiencies? a) Vitamin B12 b) Vitamin K c) Vitamin C d) Vitamin D
a) Vitamin B12
A health care professional is caring for a patient who is about ot begin alteplase (Activase) therapy to treat pulmonary embolism. Which of the following drugs should the health care professional have available in the event of a severe adverse reaction? a) Vitamin K b) Aminocaproic acid (Amicar) c) Protamine d) Deferoxamine (Deseferal)
b) Aminocaproic acid (Amicar)
A health care professional is caring for patient who has mild hemophilia A and is about to begin taking desmopressin (DDAVP) to prevent bleeding. The health care professional should monitor for which of the following adverse reactions? a) Weight loss b) Edema c) Polyuria d) Tachycardia
b) Edema
A health care professional is caring for a patient who is about to begin alteplase (Activase) therapy. The health care professional should monitor the patient for which of the following indications of a possible adverse effect? a) Hives b) Headache c) Edema d) Hypertension
b) Headache
A health care professional is administering epoetin alfa (Epogen) subcutaneously to a patient who has renal failure. The health care professional should take which of the following actions? a) Shake the vial before using b) Insert the needle into vial once c) Dilute the drug first with normal saline d) Save the used vial for the next dose
b) Insert the needle into vial once
A health care professional is caring for a patient who is about to begin taking clopidogrel (Plavix) to prevent thrombus formation. The health care professional should question the use of clopidogrel by a patient who has which of the following? a) Myocardial infarction b) Peptic ulcer disease c) Pancreatitis d) Myasthenia gravis
b) Peptic ulcer disease
A health care professional is caring for a patient who is about ot begin taking folic acid to treat megaloblastic anemia. The health care professional should monitor which of the following laboratory values? a) Amylase level b) Reticulocyte count c) C-reactive protein d) Creatinine clearance
b) Reticulocyte count
A patient is about to begin therapy with recombinant factor IX (BeneFix) to treat hemophilia B. The patient asks the health care professional about the risk of disease transmission with recombinant factor IX, as compared with plasma-derived factor IX. The health care professional should explain that recombinant factor IX eliminates the risk of which of the following? a) HIV b) Cytomegalovirus c) Creutzfeldt-jakob disease d) Anaphylaxis
c) Creutzfeldt-jakob disease
A health care professional is caring for a patient who is about to begin taking filgrastim (Neupogen) to treat neutropenia. The health care professional should assess the patient for which of the following adverse effects? a) Dusky nails bed b) Petechiae c) Enlarged spleen d) Swollen calf
c) Enlarged spleen
A health care professional is caring for a patient who has a known sensitivity to Escherichia coli-derived proteins. This sensitivity is a contraindication for which of the following drugs? a) Epoetin alfa (Erythropoietin) b) Oprelvekin (Neumega) c) Filgrastim (Neupogen) d) Alteplase (Activase)
c) Filgrastim (Neupogen)
A patient who is taking ferrous sulfate (Feosol) to treat iron-deficiency anemia develops severe nausea and vomiting due to iron toxicity. Which of the following drugs should the health care professional use to treat this complication? a) Flumazenil (Mazicon) b) Acetylcysteine (Acetadote) c) Naloxone d) Deferoxamine (Desferal)
d) Deferoxamine (Desferal)
A health care professional is caring for a patient who is about to begin taking warfarin (Coumadin). The health care professional should caution the patient about taking which of the following over-the-counter drugs? a) Diphenhydramine b) Dimenhydrinate (Dramamine) c) Calcium carbonate (Tums) d) Ibuprofen (Motrin)
d) Ibuprofen (Motrin)
A health care professional is caring for a patient who is about to begin taking ferrous sulfate (Feosol) to treat iron-deficiency anemia. When talking with the patient about the drug, the health care professional should include which of the following instructions? (Select all that apply) a) Eat iron-enriched foods b) Spread the dosage across each day c) Take the drug on an empty stomach d) Report dark green or black stools e) Increase dietary fiber intake
a) Eat iron-enriched foods b) Spread the dosage across each day c) Take the drug on an empty stomach d) Increase dietary fiber intake
A health care professional is caring for a patient who is about to begin factor III (Advate) therapy to treat hemophilia A. When administering factor VIII, which of the following actions should the health care professional take? a) Have emergency equipment ready b) Premedicate with aspirin (Ecotrin) c) Administer via rapid IV bolus d) Administer the powdered form orally
a) Have emergency equipment ready
A health care professional administers epoetin alfa (Epogen) subcutaneously to a patient who has renal failure. The health care professional should monitor the patient for which of the following adverse effects? a) Hypertension b) Muscle pain c) Edema d) Dry mouth
a) Hypertension
A health care professional is caring for a patient who is undergoing bone marrow transplantation following high-dose chemotherapy. Which of the following drugs should the health care professional expect the primary care provider to prescribe the reduce the patient's risk of infection? a) Epoetin alfa (Erythropoietin) b) Oprelvekin (Neumega) c) Filgrastim (Neupogen) d) Alteplase (Activase)
c) Filgrastim (Neupogen)
A health care professional is caring for a patient who is about to begin taking epoetin alfa (Epogen). Which of the following laboratory values should increase with effective therapy? a) PT b) WBC c) Hgb d) Platelets
c) Hgb
A health care professional is caring for a patient who is about to begin taking oprelvekin (Neumega). The health care professional should explain to the patient that the drug has which of the following effects? a) Stimulates leukocyte maturation b) Causes myelosupression c) Increases platelet production d) Destroys blood clots
c) Increases platelet production
A health care professional is caring for a patient who is about to begin taking asprin (Ecotrin) to reduce the risk of a cardiovascular event. The health care professional should understand that the drug inhibits platelet aggregation by which of the following mechanisms? a) Activating thromboxane A2 b) Blocking adenosine diphosphate receptor agonists c) Supressing specific clotting factors d) Inhibiting cyclooxygenase action in platelets
d) Inhibiting cyclooxygenase action in platelets
A patient who is taking warfarin (Coumadin) arrives at the emergency department and reports rectal bleeding. Which of the following drugs should the health care professional have available? a) Filgrastim (Neupogen) b) Deferoxamine (Desferal) c) Protamine d) Vitamin K
d) Vitamin K
A health care professional is caring for a patient who is about to begin taking alteplase (Activase) to treat acute myocardial infarction. The health care professional should understand the drug is most effective when the patient receives it a) 24 hour after clot formation b) After initiation of anticoagulation c) Prior to clot formation d) Within 3 hour of symptom onset
d) Within 3 hour of symptom onset